Mumbai, India

Vishal Jadhav


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Vishal Jadhav: Innovator in Pharmaceutical Compositions

Introduction

Vishal Jadhav is a notable inventor based in Mumbai, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions for treating various medical conditions. His work is characterized by a focus on improving the efficacy and delivery of pharmaceutical agents.

Latest Patents

Vishal Jadhav holds 1 patent for his invention titled "Pharmaceutical compositions of apremilast." This invention relates to a disintegrant-free pharmaceutical composition that includes apremilast or its pharmaceutically acceptable salts, along with one or more pharmaceutically acceptable excipients. The composition is designed to be an immediate-release dosage form, specifically aimed at treating psoriatic arthritis and psoriasis. The patent also details the process of preparing such compositions, highlighting its potential benefits in therapeutic applications.

Career Highlights

Vishal Jadhav is currently associated with Unichem Laboratories Limited, a prominent player in the pharmaceutical industry. His role at the company allows him to leverage his expertise in drug formulation and development, contributing to the advancement of healthcare solutions.

Collaborations

Throughout his career, Vishal has collaborated with several talented professionals, including Dhananjay Govind Sathe and Srikant V Pimple. These collaborations have fostered a productive environment for innovation and have led to the successful development of new pharmaceutical products.

Conclusion

Vishal Jadhav's contributions to pharmaceutical compositions demonstrate his commitment to advancing medical science. His innovative work in creating effective treatments for psoriatic arthritis and psoriasis showcases the importance of research and development in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…